Valuation: GENFIT

Market Cap 446M 509M 421M 384M 719M 48.74B 724M 5.04B 1.95B 24.9B 1.91B 1.87B 80.02B P/E 2026 *
34.5x
P/E 2027 * 95.4x
Enterprise Value 395M 450M 373M 340M 637M 43.16B 641M 4.47B 1.73B 22.05B 1.69B 1.65B 70.86B EV / Sales 2026 *
4.21x
EV / Sales 2027 * 2.92x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-1.44%
1 week-22.84%
Current month-36.92%
1 month-37.27%
3 months-12.20%
6 months+4.94%
Current year+69.42%
1 week 8.66
Extreme 8.66
11.6
1 month 8.66
Extreme 8.66
14.98
Current year 5.05
Extreme 5.05
15.48
1 year 3.13
Extreme 3.13
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
3/5/26 A Exercice

Chief Operating Officer

11,250 0.0225%
3/5/26 A Exercice

Chief Operating Officer

7,083 0.0142%
3/5/26 A Sell

Chief Operating Officer

7,083 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-22.84%+184.98%+181.39% 509M
-0.14%+4.33%+9.00%+31.64% 47.97B
-1.69%+1.48%+50.57%+34.53% 44.5B
+2.56%+7.34%+366.69%+608.26% 43.93B
+0.24%+2.85%+10.67%+94.47% 41.03B
-0.62%-1.11%+4.65%+48.91% 29.85B
-0.28%+1.07%+24.58%+155.58% 17.27B
+3.37%+9.21%+8.32% - 15.34B
-0.46%+1.20%+26.90%+42.21% 15.3B
-2.21%-4.70% - - 14.82B
Average -0.07%-0.17%+76.26%+149.62% 27.05B
Weighted average by Cap. +0.10%+2.82%+79.88%+160.32%

Financials

2026 *2027 *
Net sales 93.77M 107M 88.56M 80.71M 151M 10.24B 152M 1.06B 410M 5.23B 401M 393M 16.82B 130M 148M 123M 112M 209M 14.19B 211M 1.47B 569M 7.25B 556M 544M 23.29B
Net income 18.4M 20.97M 17.38M 15.84M 29.65M 2.01B 29.86M 208M 80.56M 1.03B 78.74M 77.04M 3.3B 10.37M 11.81M 9.79M 8.92M 16.7M 1.13B 16.82M 117M 45.38M 578M 44.36M 43.4M 1.86B
Net Debt -51.11M -58.24M -48.27M -43.99M -82.34M -5.58B -82.93M -578M -224M -2.85B -219M -214M -9.17B -67.56M -76.99M -63.81M -58.15M -109M -7.38B -110M -764M -296M -3.77B -289M -283M -12.12B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
25/09/26 €8.920 -1.44% 916,352
24/09/26 €9.050 -11.27% 947,432
23/09/26 €10.20 -2.11% 468,484
22/09/26 €10.42 -4.05% 433,822
21/09/26 €10.86 -6.06% 460,995
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
8.920EUR
Average target price
17.06EUR
Spread / Average Target
+91.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock